The median time from EGFR-TKI initiation to tumor resection was 5.9 [3.0–9.3] and 4.3 [3.5–7.4] months in patients receiving first-generation and second-generation EGFR-TKI, respectively. The gene discussed is EGFR; the disease is neoplasm.